| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |